Prudential Financial’s MaxCyte MXCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-15,285
Closed -$10.7K 2554
2026
Q1
$10.7K Buy
+15,285
New +$14.3K ﹤0.01% 2394
2025
Q4
Sell
-12,130
Closed -$19.2K 2355
2025
Q3
$19.2K Hold
12,130
﹤0.01% 2403
2025
Q2
$26.4K Buy
+12,130
New +$29.4K ﹤0.01% 2385
2025
Q1
Sell
-15,630
Closed -$65K 2348
2024
Q4
$65K Buy
+15,630
New +$59.1K ﹤0.01% 2189

Other funds holding MXCT

Prudential Financial's MXCT Position: Q2 2026 in Review

Prudential Financial sold out of MaxCyte (MXCT) in Q2 2026, closing a stake of 15,285 shares — an estimated $10.7K sold.

Prudential Financial first reported a position in MXCT in Q4 2024 and held it in 4 quarters. The position peaked at $65K in Q4 2024. 122 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.

  • Prudential Financial reported no remaining MaxCyte position as of Q2 2026 after selling out during the quarter.
  • Prudential Financial sold 15,285 MaxCyte shares in Q2 2026, an estimated $10.7K.
  • Prudential Financial first reported a position in MaxCyte in Q4 2024 and held it in 4 quarters.
  • Prudential Financial's MaxCyte position peaked at $65K in Q4 2024.
  • 122 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.